# To Evaluate the Pharmacokinetic Interactions and Safety in Healthy Volunteers

> **NCT05351840** · PHASE1 · COMPLETED · sponsor: **JW Pharmaceutical** · enrollment: 31 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LivaloV
- **DRUG:** A
- **DRUG:** LivaloVA

## Key facts

- **NCT ID:** NCT05351840
- **Lead sponsor:** JW Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-02
- **Primary completion:** 2020-12-19
- **Final completion:** 2021-01-15
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2022-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05351840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05351840, "To Evaluate the Pharmacokinetic Interactions and Safety in Healthy Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05351840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*